Showing results (151-160 of 233) with videos related to

Sort By:
Pageof 24
Journal of Clinical Pathology|February 3, 2009
A simultaneous occurrence of Tolosa-Hunt syndrome and fibrillary glomerulonephritis: a case reportA Gigante, K Giannakakis, M Visentini, et al.
Journal of Clinical Microbiology|November 1, 1983
Detection and partial characterization of circulating immune complexes in hydatid diseaseR D'Amelio, O Pontesilli, L Palmisano, et al.
AIDS Research and Human Retroviruses|March 10, 2000
HIV type 1-induced inhibition of CD45 tyrosine phosphatase activity correlates with disease progression and apoptosis, but not with anti-CD3-induced T cell proliferationA Giovannetti, M Pierdominici, F Mazzetta, et al.
Regulatory Peptides|March 5, 1992
Modulation of human natural killer activity by vasoactive intestinal peptide (VIP) family. VIP, glucagon and GHRF specifically inhibit NK activityM C Sirianni, B Annibale, F Tagliaferri, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Spectrotype of anti-gp120 antibodies remains stable during the course of HIV diseaseR D'Amelio, R Biselli, R Nisini, et al.
Clinical and Experimental Immunology|October 1, 1995
HCV infection in patients with primary defects of immunoglobulin productionI Quinti, F Pandolfi, R Paganelli, et al.
AIDS (London, England)|March 1, 1993
Fibroblast-derived factors preserve viability in vitro of mononuclear cells isolated from subjects with HIV-1 infectionF Pandolfi, A Oliva, G Sacco, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1997
C-C chemokines, IL-16, and soluble antiviral factor activity are increased in cloned T cells from subjects with long-term nonprogressive HIV infectionE Scala, G D'Offizi, R Rosso, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|January 1, 1989
Alpha interferon treatment in HIV infected patients restores gamma interferon production in vitroR Paganelli, M R Capobianchi, G P D'Offizi, et al.
Human Immunology|January 5, 2002
Distribution of the natural killer-related receptor for HLA-C during highly active antiretroviral therapy for human immunodeficiency virus infectionM C Sirianni, F Ensoli, C Alario, et al.
Pageof 24